XTANT MEDICAL HOLDINGS, INC. Foreign Currency Transaction Gain (Loss), Unrealized
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Foreign Currency Transaction Gain (Loss), Unrealized of $23.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was $23.00K, a 87.08% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was -$1.00K, a 104.17% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$206.00K.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was -$56.00K, a 307.41% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$60.00K, a 1300.00% decline from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2024 was $5.00K, a 98.11% decline from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $265.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.00K 10-Q · filed 2026-08-11 | $22.00K 10-Q · filed 2026-08-11 | -$184.00K derived: sum of 3 quarters · filed 2026-08-11 | -$240.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-13 | -$207.00K derived: sum of 2 quarters · filed 2026-05-13 | -$263.00K derived: sum of 3 quarters · filed 2026-05-13 | -$85.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$262.00K derived: sum of 2 quarters · filed 2026-03-31 | -$84.00K derived: sum of 3 quarters · filed 2026-08-11 | -$60.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$56.00K 10-Q · filed 2025-11-10 | $122.00K derived: sum of 2 quarters · filed 2026-08-11 | $146.00K 10-Q · filed 2025-11-10 | $45.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $178.00K 10-Q · filed 2026-08-11 | $202.00K 10-Q · filed 2026-08-11 | $101.00K derived: sum of 3 quarters · filed 2026-08-11 | $128.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $24.00K 10-Q · filed 2026-05-13 | -$77.00K derived: sum of 2 quarters · filed 2026-05-13 | -$50.00K derived: sum of 3 quarters · filed 2026-05-13 | $68.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$74.00K derived: sum of 2 quarters · filed 2026-03-31 | $44.00K derived: sum of 3 quarters · filed 2026-03-31 | $5.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $27.00K 10-Q · filed 2025-11-10 | $145.00K derived: sum of 2 quarters · filed 2025-11-10 | $106.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $118.00K 10-Q · filed 2025-08-12 | $79.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$39.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $265.00K 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |